News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
Syneron Medical Cuts IPO Price Range To $12-$13 A Share From $14-$16
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Underwriters for Syneron Medical Ltd., a provider of tools for use in non-invasive aesthetic medical procedures, have cut the estimated price range for the company's pending initial public offering to $12 to $13 a share from $14 to $16 a share.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Mergers & acquisitions
Concentra Snags Another Struggling Biotech as Cargo Accepts $200M Buyout
July 8, 2025
·
1 min read
·
Annalee Armstrong
Mergers & acquisitions
Sage’s Search for Lifeline Ran Into Defiant Biogen CEO
July 3, 2025
·
3 min read
·
Annalee Armstrong
Deals
Bluebird Go-Private Deal Signals the ‘PE-ization of Pharma’
July 2, 2025
·
7 min read
·
Annalee Armstrong
Mergers & acquisitions
June’s Busy Buyout Binge Bolsters M&A Stats for H1
July 1, 2025
·
4 min read
·
Annalee Armstrong